FDA approves new painkiller that shows promise and challenges of opioid alternatives
Vertex has attracted interest from Wall Street for its ambitious drug pipeline that involves winning FDA approval for ...
FDA approves Journavx, the first new painkiller in over two decades
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
The Motley Fool4d
Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?
Journavx is the first new type of painkiller approved in more than 20 years ... you can pick up shares of Vertex Pharmaceuticals for about 24.7 times forward-looking earnings expectations.
WBUR6d
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
The U.S. Food and Drug Administration said it approved Boston-based Vertex Pharmaceuticals ... It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering ...
The Greeley Tribune6d
FDA approves new painkiller that shows promise and challenges of opioid alternatives
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries. It’s the first new pharmaceutical approach to ...
WRAL6d
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
It’s the first new pharmaceutical approach to treating pain in more than 20 ... many times more expensive than comparable opioids, which are often available as generics for $1 or less. Vertex ...